Anaphylaxis to rocuronium [PDF]
British Journal of Anaesthesia, 2002 Reports about anaphylactic and anaphylactoid reactions to rocuronium have increased recently. We report two new cases of documented grade III anaphylaxis, leading to death in one patient. The first case occurred in an 81-year-old ASA II woman scheduled for emergency abdominal surgery.
C, Baillard +6 more
openaire +3 more sources
Treatment of rocuronium-induced anaphylaxis using sugammadex - A case report - [PDF]
Anesthesia and Pain Medicine, 2021 Background Perioperative anaphylaxis is a life-threatening clinical condition characterized by severe respiratory and cardiovascular manifestations. Neuromuscular blocking agents are the most common cause of anaphylaxis during anesthesia.
Sun-Min Kim, Sei-hoon Oh, Seung-Ah Ryu
doaj +2 more sources
Rocuronium for Treatment of Sugammadex Anaphylaxis: A Case Report [PDF]
Case Reports in AnesthesiologyAnaphylaxis presents as a complex and unpredictable intraoperative emergency. Rocuronium is among the most common triggering agents for intraoperative anaphylaxis.
Logan H. Cone +2 more
doaj +2 more sources
Median effective dose of rocuronium for the prevention of succinylcholine-induced fasciculation: an age-stratified study [PDF]
BMC AnesthesiologyBackground Succinylcholine, a commonly used depolarizing neuromuscular blocking relaxant, may produce fasciculation and postoperative myalgia as adverse effects.
Shunping Tian +7 more
doaj +2 more sources
Effects of sugammadex and rocuronium on electro-mechanical activity of cardiac myocytes [PDF]
Korean Journal of AnesthesiologyBackground Sugammadex reverses the effects of steroidal neuromuscular-blocking agents, such as rocuronium, by encapsulating these agents. Its cardiovascular adverse effects include QTc prolongation, hypotension, bradycardia, atrioventricular block ...
Oguzhan Arun +6 more
doaj +2 more sources
Indian Journal of Anaesthesia, 2011 Background: Rocuronium produces faster neuromuscular blockade compared with other neuromuscular blocking drugs. It produces comparable intubating conditions to that of succinylcholine, but does not have the short intubation time of the latter.
M Hanumantha Rao +2 more
doaj +2 more sources
Dilution and slow injection reduces the incidence of rocuronium-induced withdrawal movements in children [PDF]
Korean Journal of Anesthesiology, 2011 BackgroundThe aim of this study was to evaluate whether slow injection of diluted rocuronium could reduce rocuronium-induced withdrawal movements effectively in children.MethodsAfter loss of consciousness, rocuronium 0.6 mg/kg was administered into 171 ...
Young Hee Shin +8 more
doaj +1 more source
Rocuronium Bromide Inhibits Inflammation and Pain by Suppressing Nitric Oxide Production and Enhancing Prostaglandin E Synthesis in Endothelial Cells [PDF]
International Neurourology Journal, 2016 Purpose Rocuronium bromide is a nondepolarizing neuromuscular blocking drug and has been used as an adjunct for relaxation or paralysis of the skeletal muscles, facilitation of endotracheal intubation, and improving surgical conditions during general ...
Sang Bin Baek +7 more
doaj +1 more source
Pharmacological interventions for acceleration of the onset time of rocuronium: a meta-analysis. [PDF]
PLoS ONE, 2014 Rocuronium is an acceptable alternative when succinylcholine is contraindicated for facilitating the endotracheal intubation. However, the onset time of rocuronium for good intubation condition is still slower than that condition of succinylcholine. This
Jing Dong +4 more
doaj +1 more source
The antagonistic effect of neostigmine on rocuronium-, clindamycin-, or both-induced neuromuscular blocking in the rat phrenic nerve-hemidiaphragm [PDF]
Korean Journal of Anesthesiology, 2011 BackgroundNeostigmine augments clindamycin-induced neuromuscular block and antagonizes rocuronium-induced neuromuscular block; however, it remains unclear whether neostigmine enhances the neuromuscular blocking (NMB) that is caused by combinations of ...
Seung Soo Kim +3 more
doaj +1 more source